226 related articles for article (PubMed ID: 25183304)
1. Efficacy of azithromycin in the treatment of bronchiectasis.
Lourdesamy Anthony AI; Muthukumaru U
Respirology; 2014 Nov; 19(8):1178-82. PubMed ID: 25183304
[TBL] [Abstract][Full Text] [Related]
2. The disease-modifying effects of twice-weekly oral azithromycin in patients with bronchiectasis.
Cymbala AA; Edmonds LC; Bauer MA; Jederlinic PJ; May JJ; Victory JM; Amsden GW
Treat Respir Med; 2005; 4(2):117-22. PubMed ID: 15813663
[TBL] [Abstract][Full Text] [Related]
3. Phase 3 randomized study of the efficacy and safety of inhaled dry powder mannitol for the symptomatic treatment of non-cystic fibrosis bronchiectasis.
Bilton D; Daviskas E; Anderson SD; Kolbe J; King G; Stirling RG; Thompson BR; Milne D; Charlton B;
Chest; 2013 Jul; 144(1):215-225. PubMed ID: 23429964
[TBL] [Abstract][Full Text] [Related]
4. Azithromycin for prevention of exacerbations in non-cystic fibrosis bronchiectasis (EMBRACE): a randomised, double-blind, placebo-controlled trial.
Wong C; Jayaram L; Karalus N; Eaton T; Tong C; Hockey H; Milne D; Fergusson W; Tuffery C; Sexton P; Storey L; Ashton T
Lancet; 2012 Aug; 380(9842):660-7. PubMed ID: 22901887
[TBL] [Abstract][Full Text] [Related]
5. Effects of long-term low-dose azithromycin in patients with non-CF bronchiectasis.
Anwar GA; Bourke SC; Afolabi G; Middleton P; Ward C; Rutherford RM
Respir Med; 2008 Oct; 102(10):1494-6. PubMed ID: 18653323
[TBL] [Abstract][Full Text] [Related]
6. Effect of azithromycin maintenance treatment on infectious exacerbations among patients with non-cystic fibrosis bronchiectasis: the BAT randomized controlled trial.
Altenburg J; de Graaff CS; Stienstra Y; Sloos JH; van Haren EH; Koppers RJ; van der Werf TS; Boersma WG
JAMA; 2013 Mar; 309(12):1251-9. PubMed ID: 23532241
[TBL] [Abstract][Full Text] [Related]
7. Effects of long-term azithromycin therapy on airway oxidative stress markers in non-cystic fibrosis bronchiectasis.
Diego AD; Milara J; Martinez-Moragón E; Palop M; León M; Cortijo J
Respirology; 2013 Oct; 18(7):1056-62. PubMed ID: 23714268
[TBL] [Abstract][Full Text] [Related]
8. Phase II study of a neutrophil elastase inhibitor (AZD9668) in patients with bronchiectasis.
Stockley R; De Soyza A; Gunawardena K; Perrett J; Forsman-Semb K; Entwistle N; Snell N
Respir Med; 2013 Apr; 107(4):524-33. PubMed ID: 23433769
[TBL] [Abstract][Full Text] [Related]
9. Inhaled mannitol for the treatment of mucociliary dysfunction in patients with bronchiectasis: effect on lung function, health status and sputum.
Daviskas E; Anderson SD; Gomes K; Briffa P; Cochrane B; Chan HK; Young IH; Rubin BK
Respirology; 2005 Jan; 10(1):46-56. PubMed ID: 15691238
[TBL] [Abstract][Full Text] [Related]
10. Eight-weekly intravenous antibiotics is beneficial in severe bronchiectasis.
Mandal P; Sidhu MK; Donaldson LS; Chalmers JD; Smith MP; Turnbull K; Scott J; Hill AT
QJM; 2013 Jan; 106(1):27-33. PubMed ID: 23019590
[TBL] [Abstract][Full Text] [Related]
11. Inflammatory Responses, Spirometry, and Quality of Life in Subjects With Bronchiectasis Exacerbations.
Guan WJ; Gao YH; Xu G; Lin ZY; Tang Y; Li HM; Lin ZM; Jiang M; Zheng JP; Chen RC; Zhong NS
Respir Care; 2015 Aug; 60(8):1180-9. PubMed ID: 26060319
[TBL] [Abstract][Full Text] [Related]
12. Characterization of lung function impairment in adults with bronchiectasis.
Guan WJ; Gao YH; Xu G; Lin ZY; Tang Y; Li HM; Lin ZM; Zheng JP; Chen RC; Zhong NS
PLoS One; 2014; 9(11):e113373. PubMed ID: 25405614
[TBL] [Abstract][Full Text] [Related]
13. Inhaled mannitol for non-cystic fibrosis bronchiectasis: a randomised, controlled trial.
Bilton D; Tino G; Barker AF; Chambers DC; De Soyza A; Dupont LJ; O'Dochartaigh C; van Haren EH; Vidal LO; Welte T; Fox HG; Wu J; Charlton B;
Thorax; 2014 Dec; 69(12):1073-9. PubMed ID: 25246664
[TBL] [Abstract][Full Text] [Related]
14. Neutrophil extracellular traps, disease severity, and antibiotic response in bronchiectasis: an international, observational, multicohort study.
Keir HR; Shoemark A; Dicker AJ; Perea L; Pollock J; Giam YH; Suarez-Cuartin G; Crichton ML; Lonergan M; Oriano M; Cant E; Einarsson GG; Furrie E; Elborn JS; Fong CJ; Finch S; Rogers GB; Blasi F; Sibila O; Aliberti S; Simpson JL; Huang JTJ; Chalmers JD
Lancet Respir Med; 2021 Aug; 9(8):873-884. PubMed ID: 33609487
[TBL] [Abstract][Full Text] [Related]
15. A randomized controlled trial of nebulized gentamicin in non-cystic fibrosis bronchiectasis.
Murray MP; Govan JR; Doherty CJ; Simpson AJ; Wilkinson TS; Chalmers JD; Greening AP; Haslett C; Hill AT
Am J Respir Crit Care Med; 2011 Feb; 183(4):491-9. PubMed ID: 20870753
[TBL] [Abstract][Full Text] [Related]
16. The development and validation of the Bronchiectasis Health Questionnaire.
Spinou A; Siegert RJ; Guan WJ; Patel AS; Gosker HR; Lee KK; Elston C; Loebinger MR; Wilson R; Garrod R; Birring SS
Eur Respir J; 2017 May; 49(5):. PubMed ID: 28495688
[TBL] [Abstract][Full Text] [Related]
17. Idiopathic chronic productive cough and response to open-label macrolide therapy: An observational study.
Martin MJ; Lee H; Clayton C; Pointon K; Soomro I; Shaw DE; Harrison TW
Respirology; 2019 Jun; 24(6):558-565. PubMed ID: 30722097
[TBL] [Abstract][Full Text] [Related]
18. Long-term azithromycin for Indigenous children with non-cystic-fibrosis bronchiectasis or chronic suppurative lung disease (Bronchiectasis Intervention Study): a multicentre, double-blind, randomised controlled trial.
Valery PC; Morris PS; Byrnes CA; Grimwood K; Torzillo PJ; Bauert PA; Masters IB; Diaz A; McCallum GB; Mobberley C; Tjhung I; Hare KM; Ware RS; Chang AB
Lancet Respir Med; 2013 Oct; 1(8):610-620. PubMed ID: 24461664
[TBL] [Abstract][Full Text] [Related]
19. Neomacrolides in the treatment of patients with severe asthma and/or bronchiectasis: a retrospective observational study.
Coeman M; van Durme Y; Bauters F; Deschepper E; Demedts I; Smeets P; Joos G; Brusselle G
Ther Adv Respir Dis; 2011 Dec; 5(6):377-86. PubMed ID: 21890536
[TBL] [Abstract][Full Text] [Related]
20. Long-term benefits of airway clearance in bronchiectasis: a randomised placebo-controlled trial.
Muñoz G; de Gracia J; Buxó M; Alvarez A; Vendrell M
Eur Respir J; 2018 Jan; 51(1):. PubMed ID: 29326318
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
